Why Exact Sciences (EXAS) Dipped More Than Broader Market Today [Yahoo! Finance]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
This change lagged the S&P 500's daily loss of 0.58%. Elsewhere, the Dow saw a downswing of 0.12%, while the tech-heavy Nasdaq depreciated by 1.15%. Prior to today's trading, shares of the molecular diagnostics company had gained 3.17% over the past month. This has outpaced the Medical sector's loss of 6.07% and the S&P 500's loss of 1.09% in that time. The investment community will be closely monitoring the performance of Exact Sciences in its forthcoming earnings report. The company is scheduled to release its earnings on May 8, 2024. In that report, analysts expect Exact Sciences to post earnings of -$0.50 per share. This would mark a year-over-year decline of 19.05%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $624.95 million, up 3.73% from the year-ago period. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$0.86 per share and revenue of $2.83 billion, indicating changes of +23.89% and +13.32%, respectively,
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Exact Sciences gains 6% following data on blood-based colorectal cancer test [Seeking Alpha]Seeking Alpha
- ESMO 2024: Exact Sciences unveils results from cancer algorithm trial [Yahoo! Finance]Yahoo! Finance
- Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024 [Yahoo! Finance]Yahoo! Finance
- Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024Business Wire
- Exact Sciences Co. (NASDAQ: EXAS) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $75.00 price target on the stock.MarketBeat
EXAS
Earnings
- 7/31/24 - Beat
EXAS
Sec Filings
- 9/19/24 - Form 4
- 9/18/24 - Form 144
- 8/6/24 - Form 4
- EXAS's page on the SEC website